EW Insider Trading

Insider Ownership Percentage: 1.29%
Insider Buying (Last 12 Months): $49,729.20
Insider Selling (Last 12 Months): $15,461,031.53

Edwards Lifesciences Insider Trading History Chart

This chart shows the insider buying and selling history at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$684ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

Edwards Lifesciences Share Price & Price History

Current Price: $71.56
Price Change: Price Increase of +0.356 (0.50%)
As of 04/17/2025 04:59 PM ET

This chart shows the closing price history over time for EW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$71.56Closing price on 04/19/25:

SEC Filings (Institutional Ownership Changes) for Edwards Lifesciences (NYSE:EW)

79.46% of Edwards Lifesciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EW by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$42Mbought$45MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40B-$20B$0$20B$40BTotal InflowsTotal Outflows
Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More on Edwards Lifesciences

Today's Range

Now: $71.56
Low: $70.55
High: $72.15

50 Day Range

MA: $71.31
Low: $67.04
High: $76.23

52 Week Range

Now: $71.56
Low: $58.93
High: $95.25

Volume

3,235,636 shs

Average Volume

4,931,213 shs

Market Capitalization

$42.07 billion

P/E Ratio

10.27

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Edwards Lifesciences?

Edwards Lifesciences' top insider shareholders include:
  1. Larry L Wood (Insider)
  2. Jean-Luc M Lemercier (VP)
  3. Michael A Mussallem (Director)
  4. Michael A Mussallem (CEO)
  5. Bernard J Zovighian (CEO)
  6. Kieran Gallahue (Director)
  7. Steven R Loranger (Director)
  8. Donald E Bobo Jr (VP)
  9. Catherine M Szyman (VP)
  10. Scott B Ullem (CFO)
  11. Daveen Chopra (VP)
  12. Heisz Leslie Stone (Director)
  13. Daniel J Lippis (VP)
  14. Robert WA Sellers (SVP)
Learn More about top insider investors at Edwards Lifesciences.

Who are the major institutional investors of Edwards Lifesciences?

Edwards Lifesciences' top institutional investors include:
  1. Assenagon Asset Management S.A. — 0.70%
  2. Seilern Investment Management Ltd — 0.23%
  3. Rhumbline Advisers — 0.19%
  4. Birch Hill Investment Advisors LLC — 0.13%
  5. GAMMA Investing LLC — 0.06%
  6. Handelsbanken Fonder AB — 0.04%
Learn More about top institutional investors of Edwards Lifesciences stock.

Which institutional investors are selling Edwards Lifesciences stock?

Within the previous quarter, EW stock was sold by these institutional investors:
  1. Handelsbanken Fonder AB
  2. Assenagon Asset Management S.A.
  3. Seilern Investment Management Ltd
  4. Boston Common Asset Management LLC
  5. Tobam
  6. Legacy Wealth Management LLC MS
  7. Baxter Bros Inc.
  8. Bath Savings Trust Co
In the previous year, company insiders that have sold Edwards Lifesciences company stock include:
  1. Larry L Wood (Insider)
  2. Jean-Luc M Lemercier (VP)
  3. Michael A Mussallem (Director)
  4. Michael A Mussallem (CEO)
  5. Bernard J Zovighian (CEO)
  6. Kieran Gallahue (Director)
  7. Steven R Loranger (Director)
  8. Donald E Bobo Jr (VP)
  9. Catherine M Szyman (VP)
Learn More investors selling Edwards Lifesciences stock.

Which institutional investors are buying Edwards Lifesciences stock?

During the previous quarter, EW stock was bought by institutional investors including:
  1. GAMMA Investing LLC
  2. Rhumbline Advisers
  3. Orser Capital Management LLC
  4. Inscription Capital LLC
  5. Birch Hill Investment Advisors LLC
  6. Smithbridge Asset Management Inc. DE
  7. Manitou Investment Management Ltd.
  8. Wealth Enhancement Advisory Services LLC